title: Cytomegalovirus encephalitis resistant to anti-cytomegalovirus therapy.
authors.forename: M D
authors.initials: MD
authors.lastname: Holida
authors.forename: M E
authors.initials: ME
authors.lastname: Trigg
authors.forename: S L
authors.initials: SL
authors.lastname: Rumelhart
authors.forename: N F
authors.initials: NF
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Kook
authors.forename: C
authors.initials: C
authors.lastname: Peters
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D017726:Cytomegalovirus Retinitis / Q000150:complications; D004351:Drug Resistance; D018792:Encephalitis, Viral / Q000188:drug therapy*; D017809:Fatal Outcome; D017245:Foscarnet / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000150:complications / Q000276:immunology; D008297:Male; D009894:Opportunistic Infections / Q000821:virology
chemical_list: D017245:Foscarnet; D015774:Ganciclovir